SPOTLIGHT -
Slideshow
Author(s):
Is there a link between childhood and parental asthma and risk of schizophrenia?
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Potential Label Expansion for Igalmi: Pre-Supplemental New Drug Application Meeting Package Submitted
Treating ‘Morally Objectionable’ Patients
Toward a Muscarinic Agent Solution for the Presynaptic Dopamine Problem in Schizophrenia
More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle
sNDA Submitted: Lumateperone for the Prevention of Relapse in Schizophrenia
Transformation 2.0: The GLP-1 RAs as Psychiatric Medications?